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Islet1 (Isl1) is a LIM homedomain protein that plays a pivotal role in cardiac progenitors of the second heart field. Here, lineage studies with an
inducible isl1-cre demonstrated that most Isl1 progenitors have migrated into the heart by E9. Although Isl1 expression is downregulated in most
cardiac progenitors as they differentiate, analysis of an isl1-nlacZ mouse and coimmunostaining for Isl1 and lineage markers demonstrated that
Isl1 is expressed in distinct subdomains of the heart, and in diverse cardiovascular lineages. Isl1 expression was observed in myocardial lineages
of the distal outflow tract, atrial septum, and in sinoatrial and atrioventricular node. The myocardialized septum of the outflow tract was found to
derive from Isl1 expressing cells. Isl1 expressing cells also contribute to endothelial and vascular smooth muscle lineages including smooth
muscle of the coronary vessels. Our data indicate that Isl1 is a specific marker for a subset of pacemaker cells at developmental stages examined,
and suggest genetic heterogeneity within the central conduction system and coronary smooth muscle. Our studies suggest a role for Isl1 in these
distinct domains of expression within the heart.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cardiac progenitor; Lineage; Isl1; Pacemaker; Coronary smooth muscle; Tamoxifen; Inducible CreIntroduction
Previous studies of the LIM homeodomain transcription
factor Isl1 in cardiac progenitors determined that Isl1 expression
both marked andwas required within a subset of undifferentiated
cardiac progenitors which would substantially contribute to the
developing heart (Cai et al., 2003). A majority of cells within the
outflow tract, right ventricle, and right atria, and a portion of cells
within left ventricle and left atria derived from Isl1 expressing
progenitors. These results demonstrated that the previously
described secondary or anterior heart fields which give rise to
outflow tract, or outflow tract and right ventricle, respectively
(Abu-Issa et al., 2004; Kelly and Buckingham, 2002; Mjaatvedt
et al., 2001;Waldo et al., 2001), were a subset of Isl1 progenitors.⁎ Corresponding author. Fax: +1 858 5344810.
E-mail address: syevans@ucsd.edu (S.M. Evans).
1 Both authors contributed equally.
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.12.048Retrospective clonal lineage analysis performed in mouse
embryos was consistent with there being two cardiac lineages,
the first and second lineage, which derive from the first and
second heart fields, respectively (Buckingham et al., 2005;
Meilhac et al., 2004). The second heart field corresponds to the
domain marked by isl1 expression.
Original isl1 lineage studies were performed with constitu-
tive isl1-cre mouse lines (Park et al., 2006; Srinivas et al.,
2001; Yang et al., 2006). Isl1 lineages were observed in
myocardium, endocardium, and endothelium of the aorta (Cai
et al., 2003), suggesting that Isl1 is expressed in a number of
distinct cardiovascular lineages. Initial lineage studies with an
inducible isl1-cre in postnatal heart demonstrated persistent
expression of isl1 in cells within distinct subdomains of the
heart (Laugwitz et al., 2005). Analysis of isolated, cultured isl1-
expressing cells from postnatal heart demonstrated that these
cells did not express markers of cardiomyocyte differentiation,
but could be induced to differentiate to myocyte lineages with
high efficiency (Laugwitz et al., 2005).
287Y. Sun et al. / Developmental Biology 304 (2007) 286–296The timing of isl1 progenitor migration into the heart and
identification of lineages within the heart exhibiting Isl1 expres-
sion remain to be explored. Here, we have performed experiments
with an inducible isl1-cre mouse line to investigate the timing of
isl1-progenitor migration into the forming heart. We have also
examined domains of Isl1 expression utilizing a previously unde-
scribed isl1-nlacZ knock-in mouse line, and performed coimmu-
nostaining for Isl1 and various cardiovascular lineage markers to
identify cell types exhibiting Isl1 expression within the heart.
Materials and methods
Generation of mice
Isl1 nuclear LacZ knock-in mice
To study the expression pattern and role of Isl1 in mouse development, we
generated an Isl1 nuclear LacZ (nLacZ) knock-in mouse line and an isl1
inducible Cre (MerCreMer) mouse line. 129/SV ES cell genomic DNAwas used
to PCR amplify a 4.9-kb 5′ homologous arm containing isl1 untranslated region
of exon 1 and a 3.6-kb 3′ homologous arm containing exon 2 and part of exon 3.
A short coding sequence in exon 1 including ATG would be deleted upon
homologous recombination. To construct Isl1 nLacZ knock-in targeting vector, a
SalI DNA cassette containing the LoxP-floxed nLacZ followed by hrGFP and
FRT-floxed neomycin resistant gene (FRT-mclNeo) was inserted between 5′ and
3′ homologous arms at SalI site. A BamHI site was introduced at 5′ end of 3′
arm to discriminate wild-type and targeted allele in southern blot. The targeting
vector was linearized with AscI and electroporated into mouse embryonic stem
(ES) cells. The DNAs from neomycin resistant ES cell clones were digested with
BamHI and screened for recombinant clones by southern analysis using a DNA
probe immediately distal to the 3′ arm. Wild-type allele gave rise to a 10.5 kb
band and targeted allele gave rise to a 7.5 kb band. Two recombinant clones were
used for the blastocyst injection and chimera mice were crossed to C57BL/6J
females to generate heterozygous Isl1 nLacZ knock-in mice.
Isl1-MerCreMer mice
Isl1 inducible Cre (MerCreMer) mice were generated using the same
strategy as that of isl1-nLacZ knock-in, except that a knock-in cassette
composed of MerCreMer followed by FRT-mclNeo was introduced at SalI site.
HCN4-H2B-EGFP knock-in mice
Generation and characterization of HCN4-H2B-EGFP knock-in mice will be
published elsewhere. Briefly, the targeting cassette containing histone 2B fused
EGFP (H2B-EGFP) (a gift from Kat Hadjantonakis) following FRT-mclNeo
gene was introduced by homologous recombination into HCN4 locus just before
HCN4 translation initiation site. Initial characterization of the mouse line
demonstrated that EGFP was expressed in the region of cardiac conduction
system and in a pattern similar to that published (Garcia-Frigola et al., 2003).
Tamoxifen injection
To induce MerCreMer translocation to the nucleus, pregnant mice were
given a single intraperitoneal injection of tamoxifen (sigma) at a dose of 50–
75 mg/kg at desired time points (Xu et al., 2005; Zhang et al., 2006). For earlier
embryos (E6.5 and E 7.5), we used a low dose to avoid tamoxifen toxicity.
Embryos were harvested 48 h after injection and proceeded to X-gal staining or
immunostaining.
All the experiments involving mice were carried out according to a protocol
reviewed and approved by the Institutional Animal Care and Use Committee of
UCSD, in compliance with the USA Public Health Service Policy on Humane
Care and Use of Laboratory Animals.
Embryo dissection and X-gal staining
Females with copulation plugs were considered to be at embryonic
development day 0.5 (E0.5) of gestation. Pregnant females were sacrificed atdifferent time points of gestation, and embryos were dissected from maternal
tissue, examined, and photographed. Embryos were harvested in cold PBS and
fixed for 1–2 h in 4% PFA. To optimize tissue fixation and penetrance of
X-gal substrate (Roche Molecular, Indianapolis, IN), the chest wall was
opened before fixation and in some cases the heart was dissected and
incubated in substrate. Whole embryos or hearts were incubated in X-gal
solution (5 mM K4Fe (CN)6, 5 mM K3Fe (CN)6, 2 mM MgCl2, 0.01% NP-40,
0.1%deoxycholate, 0.1% X-gal in PBS) at 37 °C. For high-resolution analysis
of βGal activity, embryos were paraffin embedded, sectioned, and counter-
stained with nuclear Fast Red.
Immunostaining
Embryos or dissected hearts were fixed overnight in 4% PFA, embedded in
OCT, and cut to 5-μm sections. The following antibodies were used: mouse
monoclonal anti-Isl1 (1:100, DSHB), rabbit anti-isl1 (1:1000, a gift from Sam
Pfaff), rabbit anti-β-gal (1: 200, Cappel, #55976), PECAM-1 (1:50, BD
Pharmingen, cat# 553708), MF-20 (1:50, DSHB), neurofilament (1:50, DSHB),
α smooth-muscle-actin (1:200, Abcam, ab7817 and ab15734), Nkx2.5 (1:50,
Santa Cruz, sc14033), and αActinin (1:800, Sigma, #A-7811). Sections were
incubated with fluorescently labeled antibodies after washing with 0.25% Triton
X-100 in PBS. The specimens mounted with Vectashield DAPI medium (Vector
Laboratory) were analyzed under a fluorescence microscope.Results
Isl1 progenitors have migrated into the heart by E9.0
Previous lineage analysis with isl1-cre;R26RlacZ embryos
demonstrated a substantial contribution of isl1 expressing
progenitors to the heart, and that isl1 mRNAwas downregulated
as these progenitors enter the heart (Cai et al., 2003). To
investigate when migration of isl1 progenitors occurs, we
performed lineage analysis with an inducible isl1-cre line, isl1-
MerCreMer (Fig. 1A, see Materials and methods; (Laugwitz et
al., 2005). Embryos which were doubly heterozygous for isl1-
MerCreMer and R26R-lacZ (Soriano, 1999) and their control
littermates, were induced with tamoxifen injected into pregnant
dams at E6, E7, E8, and E9. Embryos were harvested 48 h
following tamoxifen injection and stained with X-gal to reveal
lineages derived from cells expressing isl1-MerCreMer at the
time of injection (Figs. 1B–J). Tamoxifen activity is dependent
on the half-life of tamoxifen, 11.9 h, and persists over a 24–36 h
time period (Robinson et al., 1991; Xu et al., 2005; Zhang et al.,
2006).
Embryos injected at E6 and harvested at E8 revealed that
labeled cells had already migrated into the early linear heart tube
at both anterior and posterior poles, contributing to both
myocardium and endocardium (Figs. 1B–D). Consistent with
earlier isl1-cre lineage studies (Cai et al., 2003), left ventricular
and left atrial tissues were relatively less populated by isl1
expressing cells. Continued migration of isl1 progenitors into
the heart occurs up to approximately E8.5 (Figs. 1E–H).
However, inductions performed at E9 revealed very few cardiac
progenitors actively expressing isl1 at this time, with labeled
cells observed in the most distal outflow tract, atrial septum, and
in the region of the sinoatrial node and atrioventricular nodes
(Figs. 1I, J). These data suggest that by E9 most isl1 progenitors
have migrated into the heart and have ceased active expression
of isl1.
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289Y. Sun et al. / Developmental Biology 304 (2007) 286–296Isl1-nlacZ knock-in mice recapitulate cardiac expression of
endogenous isl1 protein and reveal subdomains of active Isl1
expression within the heart
An isl1-nlacZ knock-in mouse line was generated to readily
visualize Isl1 expression (Fig. 2A, see Materials and methods).
Analysis of lacZ expression in embryos at E8.5, E9.5, E11.5, and
E14.5 (Figs. 2B–J) revealed congruence with previously
described expression of the endogenous isl1 gene (Cai et al.,
2003; Pfaff et al., 1996). At E8.5, Isl1 is actively expressed in
outflow tract and partially in the right atria and right ventricle, but
not in the remainder of the myocardium (Figs. 2B–D). Isl1 was
asymmetrically expressed in the right atria, and became
progressively confined to a subdomain within the right atria, in
the region of the cardiac pacemaker (Figs. 2C, D, F, H). At E14.5,
isl1-nlacZ expression persisted in subdomains within the outflow
tract, aorta, pulmonary artery, right ventricle, venous valves, atrial
septum, and in regions corresponding to those of the sinoatrial
(SA) and atrioventricular (AV) nodes, and in clusters of cells in the
region of cardiac ganglia (Figs. 2I, J). At postnatal day 3, Isl1-
nlacZ expression was still observed in the region of the sinoatrial
node and at the base of the aorta/pulmonary artery, but less
extensively, with the exception of cardiac ganglia which still
exhibited strong expression (Fig. 2K).
To determine whether isl1-nlacZ expression accurately
reflected endogenous Isl1 protein expression, we performed
coimmunostaining analysis on cardiac sections, utilizing anti-
bodies to detect β-galactosidase and Isl1. At E11.5 and E13.5, β-
galactosidase colocalized with endogenous Isl1 (Figs. 3A–H and
I–K). As with X-gal staining, Isl1 was observed in outflow tract
(Figs. 3A–D), in the region of the SA andAVnodes (Figs. 3E–H),
in the atrial septum and within cells in the region of the cardiac
ganglia (Figs. 3I–K). At postnatal day 3, Isl1 was observed
coincidentwithβ-gal staining, in cardiac ganglia, the region of the
sinoatrial node (Figs. 3L, M, P, Q, T, UG), and in scattered cells
within myocardium at the base of the aorta/pulmonary artery
(Figs. 3N, O, R, S, V). Cardiac ganglia were identified by
immunostaining with antibody to neurofilament (see Figs. 7F, G).
Isl1 is actively expressed in some myocardial lineages,
including those of the sinoatrial and atrioventricular nodes
To identify cardiac lineages which express Isl1, we performed
coimmunostaining on tissue from wild-type or isl1-nlacZFig. 1. Lineage analysis of embryos doubly heterozygous for isl1-MerCreMer and R
mouse. (a) Targeting strategy. The relevant genomic region of isl1 is shown on top, th
shown at the bottom. A knock-in cassette composed of MerCreMer followed by FRT
represents the MerCerMer cDNA and gray box represents the mcl-neomycin gene. (
from neomycin-resistant ES clones were digested with BamHI and analyzed by South
wild-type and targeted alleles, respectively. (B) Embryos injected at E6 and harvested
tube at both anterior and posterior poles, contributing to both myocardium and endo
progressing from anterior to posterior and (D) Corresponding sections of ED8.5 (1
indicate positive cells in endocardium. (E, F) Embryos injected at E7 and harvested at
in outflow tract, atria, ventricle, and within mesenchymal cells of the atrioventricula
arrowheads). (I, J) Inductions performed at E9 revealed positive staining in the mos
region of the sinoatrial node and atrioventricular node (indicated by arrows). A: atria
RA: right atria; LV: left ventricle; SAN: sinoatrial node. The framed areas were shoembryos, utilizing antibodies to specific cardiac lineages and
to Isl1 orβ-galactosidase. At E11.5, coimmunostaining with Isl1
antibody and a monoclonal antibody to muscle specific myosin
heavy chain, MF20 (Bader et al., 1982; Han et al., 1992),
revealed co-expression of those two markers in outflow tract
myocardium (Figs. 4A–D). Outflow tract myocardium also
expresses α-smooth muscle actin (Beall and Rosenquist, 1990;
Kruithof et al., 2003), which also colocalizes with Isl1
expression (Figs. 4E–H). At E14.5, β-galactosidase expressing
cells at the base of the outflow tract which derived from Isl1
expressing cells, co-express α-smooth muscle actin, and MF20
(Figs. 4I–L and M–P). This population represents the
“myocardialized” proximal septum of the outflow tract which
provides continuity with the ventricular septum to divide the
heart (Kruithof et al., 2003).
To determinewhether observed expression of Isl1 in the region
of the SA and AV nodes reflected expression of Isl1 in pacemaker
cells, we performed immunostaining for Isl1 on sections obtained
from anHCN4-H2B-GFP knock-inmouse (YS, SE, unpublished)
(Figs. 4Q–T). HCN4 is a hyperpolarization activated cyclic
nucleotide gated cation channel which marks developing SA and
AV nodes in mouse embryos, and the HCN4-H2B-GFP knock-in
recapitulates expression of the endogenous gene (Garcia-Frigola
et al., 2003; YS, SE, unpublished observations). We observed
colocalization of Isl1 with some GFP expressing cells at E11.5
(Figs. 4Q–T), which demonstrated that Isl1 is expressed in at least
a subset of pacemaker cells.
We also observed Isl1 expression in the atrial septum. Co-
immunostaining on E13.5 sections demonstrated that Isl1 expres-
sing cells in this region co-expressed Nkx2.5 (Figs. 4U–X), and
α-actinin (Figs. 4Y–B′), the latter a marker for differentiated
myocytes.
Isl1 is expressed in some endothelial lineages
Previous lineage studies with isl1-cre suggested a contribu-
tion of isl1 progenitors to endothelial cells within the outflow
tract, a subset of endocardial cells, and to aortic endothelium
(Cai et al., 2003). Here, we observed active Isl1 expression in
the endothelial populations evidenced by co-expression of Isl1
and PECAM in cells within the outflow tract at E11.5 (Figs.
5A–E) and within the aorta and pulmonary artery at E12.5
(Figs. 5F–I), indicating that Isl1 is actively expressed in these
endothelial populations at this time.26R-lacZ by tamoxifen induction. (A) Generation of Isl1 MerCreMer knock-in
e targeting construct is shown in the center, and the locus after recombination is
-mclNeo was introduced at the SalI site in isl1 5′-untranslated region. Red box
b) Detection of wild-type and targeted alleles by Southern blot analysis. DNAs
ern blot with probe as shown in panel A-a. The 10.5- and 7.5-kb bands represent
at E8 revealed that labeled cells had already migrated into the early linear heart
cardium. (C) Corresponding sections of ED8.5 (8 somites) embryos are shown,
0 somites) embryos are shown, progressing from anterior to posterior. Arrows
E9 and (G, H) Embryos injected at E8 and harvested at E10 showed labeled cells
r (AV) canal (positive cells indicated by arrows and negative cells indicated by
t distal cells of the outflow tract and a distinct subset of cells in the atria, in the
; AVN: atrioventricular node; LA: left atria; LV: left ventricle; OT: outflow tract;
wn by high magnification in next photos.
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the proximal outflow tract, and the coronary vasculature
At E12.5, Isl1 colocalized with smooth muscle at the
proximal portion of the aorta and pulmonary arteries (Figs. 6A–D). Expression of Isl1 in vascular smooth muscle prompted us
to examine whether smooth muscle of the coronary vessels
might also derive, at least in part, from isl1-expressing cells.
Examination of cardiac sections from postnatal isl1-cre;R26R-
lacZ mice revealed colocalization of β-galactosidase and α-
291Y. Sun et al. / Developmental Biology 304 (2007) 286–296smooth muscle actin within some smooth muscle cells of the
coronary vessels (Figs. 6E–L). Isl1 lineage-traced cells, as
indicated by β-galactosidase expression, were observed spor-
adically within smooth muscle of the coronary vasculature both
within the left (Figs. 6E–H) and right (Figs. 6I–L) ventricles.
Isl1 lineage-traced cells were not observed in the epicardium
(Figs. 6H and L).
Isl1 is expressed in very few cells within outflow tract derived
from cardiac neural crest, but is expressed throughout cardiac
ganglia
Cardiac neural crest cells migrate into the aortic sac and
outflow tract and contribute smooth muscle to the great vessels,
and associated aortic arch arteries (Creazzo et al., 1998; Waldo
et al., 1998). As Isl1 is expressed in a number of neural crest
derivatives that give rise to sensory neurons in central and
peripheral sensory ganglia and neurons of the autonomic
nervous system, including cardiac ganglia (Kirby and Stewart,
1983; Thor et al., 1991), we investigated whether Isl1 was
expressed in cardiac neural crest cells within the outflow tract.
To visualize cells derived from cardiac neural crest, lineage
studies were performed utilizing wnt1-cre;R26RlacZ mice
(Jiang et al., 2002). Co-immunostaining for β-galactosidase
and Isl1 was performed on tissue sections from Wnt1-cre;
R26RlacZ embryos. No substantial overlap was observed
between Isl1 and β-galactosidase in outflow tract, with the
exception of a few scattered cells, suggesting that Isl1 is not
expressed in the majority of cardiac neural crest derived cells
within cardiac outflow tract (Figs. 7A–D).
Cardiac ganglia also derive from the cardiac neural crest
(Kirby and Stewart, 1983). Co-immunostaining for Isl1 and
neurofilament demonstrated that Isl1 is expressed in cardiac
ganglia (Figs. 7E–H).
Discussion
Lineage studies performed here with inducible isl1-MerCre-
Mer;R26RlacZ embryos, and previous studies with Isl1-cre;
floxed fgf8-GFP mice (Park et al., 2006) demonstrate that isl1
expressing progenitors migrate into the heart shortly following
fusion of cardiac primordia. Tamoxifen induction of Isl1-
MerCreMer;R26RlacZ embryos revealed that by E9, most isl1
progenitors have migrated into the heart, and have down-
regulated isl1 expression.Fig. 2. Analysis of β-galactosidase expression in isl1-nlacZ knock-in embryos using X
is the same as that of isl1-MerCreMer, except that the knock-in cassette is a SalI fragm
represent: blue box, nLacZ, which is flanked by Lox-P, green box, hrGFP, and gray bo
type and targeted alleles by Southern blot analysis as described in panel A-a. The 1
Embryos at E8.5 stained with X-gal in left, frontal, and right views revealed active exp
sections of ED8.5 (8 somites) embryos are shown, progressing from anterior to po
progressing from anterior to posterior, (E) embryos at E9.5 stained with X-gal in left an
isl1-nlacZ expression within outflow tract, right atria and right ventricle. Arrows indic
and right views, and (H) Corresponding sections from anterior to posterior reveale
atrioventricular nodes. (I) Heart from E14.5 embryos stained with X-gal in ventral,
dorsal revealed isl1-nlacZ expression within outflow tract, aorta, pulmonary artery, a
nodes. (K) At postnatal day 3, Isl1-nlacZ expression was observed in cardiac ganglia,
atria; AS: atria septum; AVN: atrioventricular node; CG: cardiac ganglia; LA: left aFrom E9 to postnatal day 3, Isl1 expression is observed in
select subdomains of the heart, including the outflow tract and
pacemaker cells of the sinoatrial and atrioventricular nodes.
Consistent with Isl1 expression in outflow tract myocardium,
expression of a MEF2c anterior heart field enhancer in the
outflow tract requires consensus elements recognized by Isl1
and GATA transcription factors (Dodou et al., 2004). Isl1 is
expressed in outflow tract myocardium and endocardium during
the time at which extensive outflow tract remodeling is
occurring (Kruithof et al., 2003), suggesting a potential role
for Isl1 in this process.
Although retroviral lineage studies have demonstrated a
myocytic lineage origin for His-Purkinje fibers (Gourdie et al.,
2003), no lineage studies have been performed which address
the origin of pacemaker lineages in the central conduction
system. Observed Isl1 expression in the SA and AV nodes
suggests that pacemaking cells at stages examined may arise, at
least in part, from the second heart field. HCN4 is an early
marker for nodal lineages, and we observed Isl1 expression in a
subset of the HCN4 domain, suggesting that Isl1 is actively
expressed in, and is a marker for, a subset of HCN4 positive
cells. The cardiac pacemaker is comprised of heterogeneous
cells (Anderson and Ho, 1998), and it will be of future interest to
address the properties of the subset of pacemaker cells actively
expressing Isl1. Pacemaker cells of the central conduction
system in developing heart are relatively undifferentiated
(Moorman et al., 1998), and it is interesting that this correlates
with Isl1 expression.
Previous lineage studies with a constitutive isl1-cre (Cai et al.,
2003; Yang et al., 2006) suggested that Isl1 expressing cells
contributed to endothelial cells of the aorta, endothelial cells
within the outflow tract, and a substantial number of endocardial
cells within chamber myocardium. Consistent with these results,
our data with the inducible isl1-cre demonstrated a substantial
contribution of isl1 cells to endothelial lineages, including
mesenchymal cells within outflow tract and atrioventricular
cushions. We also observed active expression of Isl1 in endo-
thelial cells of the outflow tract, aorta, and pulmonary artery.
Isl1 was actively expressed in several smooth muscle
populations, including that of the proximal portion of the
aorta and pulmonary artery, consistent with previous results
which demonstrated that this smooth muscle population derives
from the secondary or anterior heart field (Verzi et al., 2005;
Waldo et al., 2005). During outflow tract remodeling, a process
called myocardialization has been described, whereby the lower-gal staining. (A) Generation of isl1-nlacZ knock-in mice. (a) Targeting strategy
ent of Lox-P-nLacZ followed by hrGFP and FRT-mclNeo gene. Colored boxes
x, mcl-neomycin resistance gene, which is flanked by FRT. (b) Detection of wild-
0.5- and 7.5-kb bands represent wild-type and targeted alleles, respectively. (B)
ression of β-gal in foregut endoderm, splanchnic mesoderm. (C) Corresponding
sterior, (D) corresponding sections of ED8.5 (10 somites) embryos are shown,
d right views, and (F) Corresponding sections from anterior to posterior revealed
ate positive cells in endocardium. (G) Embryos at E11.5 stained with X-gal in left
d isl1-nlacZ expression within outflow tract, atrial septum, and sinoatrial and
dorsal, and lateral dorsal views, and (J) Corresponding sections from ventral to
trial septum, venous valves, cardiac ganglia, and sinoatrial and atrioventricular
the region of the sinoatrial node, and at the base of the aorta/pulmonary artery. A:
tria; LV: left ventricle; OT: outflow tract; RA: right atria; SAN: sinoatrial node.
Fig. 3. Expression of isl1-nlacZ mirrors endogenous Isl1 expression. (A–H) Co-immunostaining with antibodies to Isl1 and β-galactosidase (β-gal) on cardiac sections
of isl1-nLacZ knock-in embryos at E11.5. (I–K) Co-immunostaining of Isl1 and β-gal antibodies on cardiac sections of isl1-nLacZ knock-in embryos at E13.5. (L–T)
Co-immunostaining of Isl1 and β-gal antibodies on postnatal day 3 cardiac sections of isl1-lacZ knock-in mouse.
292 Y. Sun et al. / Developmental Biology 304 (2007) 286–296portion of the outflow tract septum expresses smooth muscle
actin and myosin heavy chain and contributes to the final
septation of the heart (Christoffels et al., 2004). The source ofFig. 4. Isl1 expression in myocardial lineages and cardiac conduction system. (
muscle specific myosin heavy chain, MF20, on sections from E11.5 (A–D) and E
Co-immunostaining of isl1 or β-gal and α-smooth muscle actin on sections fro
outflow tract myocardium. (Q–T) Co-immunostaining for isl1 on sections obtaine
of HCN4+ populations in the regions of SA node, AV node, and atrial septum (
expressing cells in atrial septum co-expressed Nkx2.5 (U–X), and α-actinin (Y–the myocardialized septum has not been identified. Analysis of
Isl1-lacZ expression revealed that these cells derive at least in
part from Isl1 expressing cells.A–D) Co-immunostaining of isl1 or β-gal with a monoclonal antibody to
14.5 (I–L) embryos revealed expression of isl1 in outflow tract myocardium.
m E11.5 (E–H) and E14.5 (M–P) embryos revealed expression of isl1 in
d from an HCN4-GFP knock-in mouse revealed expression of isl1 in subsets
arrow). Co-immunostaining of isl1 on E13.5 sections demonstrated that Isl1
B′), the latter a marker for differentiated myocytes.
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Fig. 5. Isl1 expression in endothelial lineages. Co-immunostaining for Isl1 and PECAM-1 showed expression of Isl1 protein in PECAM positive endothelial cells
within outflow tract at E11.5 (A–E) and in endothelial cells within aorta and pulmonary artery at E12.5 (F–I).
Fig. 6. Isl1 expression in smooth muscle lineages. (A–D) Coimmunostaining for Isl1 and α-smooth muscle actin in sections from E12.5 embryos showed
colocalization in proximal aorta and pulmonary artery trunk. (E–L) In the heart from postnatal day 0 (PN0) isl1-cre;R26RlacZ mouse, β-gal expressing cells
co-expressed α-smooth muscle actin in coronary vasculature in left (E–H) and right (I–L) ventricles but not in epicardium (arrow in panels H and L).
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Fig. 7. Isl1 expression in cardiac neural crest lineages. (A–D) Co-immunostaining for Isl1 and β-gal on tissue sections from Wnt1-cre;R26RlacZ embryos at E12.5
showed that only a small number of Isl1- and β-gal-positive cells overlapped in the outflow tract (arrows indicate overlapping staining). (E–H) Co-immunostaining for
Isl1 and neurofilament on tissue sections from E13.5 embryos revealed Isl1 expression in cardiac ganglia.
295Y. Sun et al. / Developmental Biology 304 (2007) 286–296The observation that Isl1 was expressed in smooth muscle
contributing to the aorta and pulmonary artery, and previously
described expression of Isl1 in neural crest derivatives (Thor et
al., 1991), led us to examine potential overlap of Isl1-expressing
cells with those derived from the cardiac neural crest (Kirby and
Stewart, 1983). Very little overlap was observed in the outflow
tract domain. However, Isl1 was expressed in cardiac ganglia
which also derive from the cardiac neural crest.
Our studies also reveal a contribution of Isl1 expressing
cells to the smooth muscle of the coronary vessels. Previous
lineage studies in chick embryos have demonstrated that
smooth muscle of the coronary vessels derives from the
proepicardium/epicardium (Gittenberger-de Groot et al., 1999;
Mikawa and Gourdie, 1996; Olivey et al., 2004). In mouse,
coronary vessels are invested with smooth muscle at approxi-
mately E15, well past the time at which the majority of isl1
progenitors of the second heart field have migrated into the
heart. We did not observe isl1-lineage traced cells in the
epicardium. The origin of the coronary smooth muscle cells
which were labeled by isl1-cre;R26R lineage tracing is
currently unknown. These cells may represent a subset of
epicardially derived cells which activate isl1 expression, may
have been conscripted from surrounding isl1-derived myocar-
dium, or may derive from another source. In any case, the
observation that a subset of smooth muscle cells derives from
an isl1 expressing lineage demonstrates genetic heterogeneity
of coronary vascular smooth muscle, which may have
implications for coronary vessel disease.
The observation that Isl1 expressing cells contribute to
multiple cardiovascular cells of distinct lineages, including
myocyte, conduction system, endothelial, and smooth muscle
lineages, raises the question as to the role of Isl1 in specification
of each of these lineages. Is Isl1 expressed in a pluripotential
cardiovascular progenitor? Or is Isl1 expressed independently
in each of the lineage-restricted precursors? The early onset of
Isl1 expression is consistent with the former, and will be a
subject for future investigation.Contribution of Isl1 expressing cells to multiple cardiovas-
cular lineages also has implications for studies utilizing isl1-cre
lines to ablate genes which may be expressed in more than one
of these lineages.
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